Certain Cancers: Increased risk of cancers such as breast, colon, and endometrial cancer
Finally, the study was conducted at two sites and included a relatively small cohort with limited ethnic diversity which may limit the generalisability of our findings
The most common adverse reactions reported in patients treated with semaglutide include nausea, vomiting, diarrhea, abdominal pain, and constipation.[5-7] Semaglutide may also increase the risk of pancreatitis, acute gallbladder disease, hypersensitivity reactions, acute kidney injury, and thyroid C-cell tumors.[5-7] Whether semaglutide is safe in people with pancreatitis remains unclear.[5-7] It is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).[5-7] How Long Will Semaglutide Weight Loss Results Last
Instead of the standard escalation from 0.25 mg weekly, this protocol starts at 0.125 mg twice weekly and increases gradually